tiprankstipranks
Enveric Biosciences (ENVB)
NASDAQ:ENVB
US Market

Enveric Biosciences (ENVB) Financial Statements

Compare
471 Followers

Enveric Biosciences Financial Overview

Enveric Biosciences's market cap is currently $2.63M. The company's EPS TTM is $-38.459; its P/E ratio is ―; Enveric Biosciences is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 39.91M
Gross Profit$ -408.03K$ -435.20K$ -681.61K$ -120.87K$ 8.15M
Operating Income$ -16.45M$ -27.42M$ -64.62M$ -5.62M$ -6.32M
EBITDA$ -16.85M$ -19.63M$ -63.97M$ -6.30M$ -2.33M
Net Income-$ -18.47M$ -48.98M$ -6.39M$ -5.60M
Balance Sheet
Cash & Short-Term Investments$ 2.29M$ 17.72M$ 17.36M$ 1.58M$ 431.40K
Total Assets$ 4.30M$ 19.55M$ 26.72M$ 4.10M$ 25.01M
Total Debt$ 0.00$ 63.82K$ 176.30K$ 0.00$ 4.88M
Net Debt$ -2.29M$ -17.66M$ -17.18M$ -1.58M$ 4.45M
Total Liabilities$ 2.34M$ 4.00M$ 4.41M$ 681.25K$ 14.38M
Stockholders' Equity$ 1.96M$ 14.67M$ 22.31M$ 3.42M$ 10.62M
Cash Flow
Free Cash Flow$ -14.10M$ -17.73M$ -12.32M$ -3.93M$ -2.54M
Operating Cash Flow$ -14.09M$ -17.15M$ -11.46M$ -3.89M$ -2.45M
Investing Cash Flow$ 11.67K$ -584.16K$ 2.19M$ -44.14K$ -284.33K
Financing Cash Flow$ -1.34M$ 18.18M$ 24.90M-$ 560.00
Currency in USD

Enveric Biosciences Earnings and Revenue History

Enveric Biosciences Debt to Assets

Enveric Biosciences Cash Flow

Enveric Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis